BEDFORD, Mass., July 29 /EMWNews/ -- Insulet Corporation

(Nasdaq: PODD), the leader in patch pump technology with its OmniPod(R)

Insulin Management System, announced plans to release its financial results

for the second quarter 2008 on Tuesday, August 12, 2008 after the close of

the financial markets.



    Insulet will also host a conference call at 5:00 p.m. Eastern Time on

Tuesday, August 12, 2008 to discuss its second quarter 2008 financial

results. During the conference call, material information concerning the

Company, its operations, strategies and prospects may be discussed.



    To listen to the conference call, please dial 800-291-5365 for domestic

callers and 617-614-3922 for international callers. The passcode is

10752938. A replay of the conference call will be available two hours after

the start of the call through August 19, 2008 by dialing 888-286-8010

(domestic) and 617- 801-6888 (international), passcode 78058481. An online

archive of the conference call will also be available by accessing the

Investor Information section of the company's website at

http://investors.insulet.com.

    About Insulet Corporation



    Insulet Corporation is an innovative medical device company dedicated

to improving the lives of people with diabetes. The Company's OmniPod

Insulin Management System is a revolutionary, discreet and easy-to-use

insulin infusion system that features two easy-to-use parts with no tubing

and fully-automated cannula insertion. Through the OmniPod System, Insulet

seeks to expand the use of continuous subcutaneous insulin infusion (CSII)

therapy among people with insulin-dependent diabetes. Founded in 2000,

Insulet is based in Bedford, MA.